Advertisement

Topics

Maxim Raises Target Price of Biotech Company

02:00 EDT 18 Aug 2017 | InvestorIdeas

August 18, 2017 (Investorideas.com Newswire) A year-over-year increase in sales of its flagship product, and the prospect that its technology could be used to promote the efficacy of cell therapies, helped spur a target price increase on this biotech.

Original Article: Maxim Raises Target Price of Biotech Company

NEXT ARTICLE

More From BioPortfolio on "Maxim Raises Target Price of Biotech Company"

Advertisement
Quick Search
Advertisement
Advertisement